Disease recurrence following liver transplantation

Clinics in Liver Disease

Volumn 4, Issue 3, 2000, Pages 675-689

  Rosen, Hugo R ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BILIARY CIRRHOSIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CANCER; LIVER DISEASE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; RECURRENT DISEASE; REVIEW; VIRUS HEPATITIS;

EID: 0033899354     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70132-X     Document Type: Article

References (57)

1. K. Abu-Elmagd J. Fung Primary cholestatic liver disease may recur after liver transplant 1999 International Liver Transplantation Society Pittsburgh
2. N. Baddour A.J. Demetris G. Shah The prevalence, rate of onset and spectrum of histologic liver disease in alcohol abusing liver allograft recipients [abstract] Gastroenterology 102 1992 A779
3. M. Berenguer L. Ferrell J. Watson HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 2000 673 684 (in print)
4. M. Berenguer T.L. Wright Treatment strategies for recurrent hepatitis C after liver transplantation Clinics in Liver Disease 4 1998 883 898
5. G.A. Berlakovich R. Steininger F. Herbst Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance Transplantation 58 1994 560 565
6. Bismuth H. Revisiting liver transplantation for patients with hilar cholangiocarcinoma: The Mayo Clinic Proposal. Liver Transplantation 6:317–319
7. M. Charlton E. Seaberg R. Wiesner Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 1998 823 830
8. J. Devlin P. Donaldson B. Portmann Recurrence of autoimmune hepatitis following liver transplantation Liver Transpl Surg 1 1995 162 165
9. H.R. Doyle F. Morelli J. McMichael Hepatic retransplantation: An analysis of risk factors associated with outcome Transplantation 61 1996 1499 1505
10. L. Dubel O. Farges H. Bismuth Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis J Hepatol 23 1995 674 680
11. R.W. Evans D.L. Manninen F.B. Dong Is retransplantation cost effective? Transplant Proc 25 1993 1694 1697
12. C. Feray M. Gigou D. Samuel Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation Ann Intern Med 10 1998 810 816
13. E. Gane Hepatitis C virus infection following liver transplantation Viral Hepatitis Reviews 4 1998 97 125
14. E.J. Gane B.C. Portmann N.V. Naoumouv Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 821 827
15. R.G. Gish A.H. Lee E.B. Keeffe Liver transplantation for patients with alcoholism and end-stage liver disease Am J Gastroenterol 88 1993 1337 1342
16. Gopal DV, Corless CL, Rabkin JM, et al. Graft failure from severe recurrent primary sclerosing cholangitis (psc) following orthotopic liver transplantation, in print
17. D.V. Gopal J. Rabkin B.S. Berk Combination interferon plus ribavirin therapy for progressive HCV recurrence following liver transplantation [abstract] Transplantation 69 2000 3125
18. I. DeVreede J.L. Steers P.A. Ruch Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma Liver Transplantation 6 2000 309 316
19. J.A. Goss C.R. Shackleton D.G. Farmer Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience Ann Surg 225 1997 472 481
20. I.W. Graziadei R.H. Wiesner K.P. Batts Recurrence of primary sclerosing cholangitis following liver transplantation Hepatology 29 1999 1050 1056
21. S.-H. B. Han P. Martin J. Ofman Combination HBIG and lamivudine is both highly efficacious and cost-effective in preventing recurrent hepatitis B in orthotopic liver transplant recipients compared to HBIG monotherapy [abstract] Hepatology 30 1999 242A
22. D.M. Harnois J. Steers J.C. Andrews Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma Liver Transpl Surg 5 1999 192 199
23. R.F. Harrison M.H. Davis J. Neuberger Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis? Hepatology 20 1994 356 361
24. J.H. Hoofnagle T. Kresina R.K. Fuller Liver transplantation for alcoholic liver disease: Executive statement and recommendations Liver Transpl Surg 3 1997 347 350
25. S. Hubscher E. Elias J. Buckels Primary biliary cirrhosis: Histological evidence of disease recurrence after liver transplantation J Hepatol 18 1993 173 184
26. D.E. Jones O.F. James B. Portmann Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis Hepatology 30 1999 53 57
27. W.R. Kim R.H. Wiesner J.J. Poterucha Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization Hepatology 30 1999 395 400
28. N.P. Lam Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa Hepatology 26 1997 226 231
29. M.R. Lucey Alcohol injury in the transplanted liver Liver Transpl Surg 3 1997 S26 S31
30. M.R. Lucey K. Carr T.P. Beresford Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study Hepatology 25 1997 1223 1227
31. J.F. Markmann J. Gornbein J.S. Markowitz A simple model to estimate survival after retransplantation of the liver Transplantation 67 1999 422 430
32. J.S. Markowitz P. Martin A.J. Conrad Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin Hepatology 28 1998 585 589
33. J.W. Marsh I. Dvorchik M. Subotin The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study Hepatology 26 1997 444 450
34. P. Milkiewicz S.G. Hubscher G. Skiba Recurrence of autoimmune hepatitis after liver transplantation Transplantation 1999 253 256
35. J. Neuberger Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis Liver Transpl Surg 1 1995 109 115
36. J. Neuberger B. Portmann R. Calne Recurrence of autoimmune chronic active hepatitis following orthotopic liver transplantation Transplantation 37 1984 363 365
37. R. Perillo J. Rakela J. Dienstag Multicenter study of lamivudine therapy for hepatitis B after liver transplantation Hepatology 29 1999 1581 1586
38. M. Prieto M. Berenguer J.M. Rayon High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes Hepatology 29 1999 250 256
39. V. Ratziu D. Samuel M. Sebagh Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease J Hepatol 30 1999 131 141
40. P. Ricci T.M. Therneau M. Malinchoc A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease Hepatology 25 1997 672 677
41. Rosen HR, Martin P. Viral hepatitis following liver transplantation. Infectious Disease Clinics of North America (in print)
42. H.R. Rosen J.P. Madden P. Martin A model to predict survival following hepatic retransplantation Hepatology 29 1999 365 369
43. H.R. Rosen D.R. Gretch E. Kaufman The humoral immune response to hepatitis C following liver transplantation: Assessment of a new recombinant immunoblot assay Am J Gastroenterol 2000
44. H.R. Rosen D.R. Gretch M. Oehlke Timing and severity of hepatitis C recurrence following liver transplantation as predictors of longterm allograft injury Transplantation 65 1998 1178 1182
45. H.R. Rosen D.J. Hinrichs D.R. Gretch Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation Gastroenterology 117 1999 926 932
46. H.R. Rosen J.J. Lentz S.L. Rose Donor polymorphism of tumor necrosis factor gene associated with variable severity of hepatitis C recurrence following liver transplantation Transplantation 68 1999 1898 1902
47. H.R. Rosen P.M. O'Reilly C.R. Shackleton Graft loss following liver transplantation in patients with chronic hepatitis C Transplantation 62 1996 1773 1776
48. H.R. Rosen C.R. Shackleton P. Martin Indications for and timing of orthotopic liver transplantation Med Clin North Am 80 1996 1069 1102
49. H.R. Rosen P. Martin Hepatitis C virus infection in patients undergoing liver retransplantation Transplantation 66 1998 1612 1616
50. F.P. Sarasin E. Giostra G. Mentha Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective Hepatology 28 1998 436 442
51. L.K. Schluger P.A. Sheiner S.N. Thung Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation Hepatology 23 1996 971 976
52. P. Sheiner O. Boros F.M. Klion The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation Hepatology 28 1998 831 838
53. N. Singh T. Gayowski C. Wannstedt Interferon-a for prophylaxis of recurrent hepatitis C in liver transplant recipients Transplantation 65 1998 82 86
54. S. Todo A. Demetris D. Van Thiel Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 1991 619
55. J. Torresi S. Locarnini Antiviral chemotherapy for the treatment of hepatitis B virus infections Gastroenterology 118 2000 S83 S103
56. W.J. Wall Recurrent disease after liver transplantation: Implications for the future Liver Transpl Surg 3 1997 S62 S67
57. T. Wong J. Devlin Rolando Clinical characteristics affecting the outcome of liver retransplantation Transplantation 27 1997 878 882